Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -80.46% is 16% above its 5-year average of -95.27%, near the high end of its 5-year range (-299.55%–-46.65%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.20% above its 12-month average of -85.78%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -80.46%.
RETURN ON EQUITY (ROE)
-80.46%
RETURN ON EQUITY (ROE) AVG TTM
-85.78%
RETURN ON EQUITY (ROE) AVG 3Y
-79.20%
RETURN ON EQUITY (ROE) AVG 5Y
-95.27%
RETURN ON EQUITY (ROE) AVG 10Y
-93.75%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.20%
CURRENT VS 3Y AVG
-1.59%
CURRENT VS 5Y AVG
+15.54%
CURRENT VS 10Y AVG
+14.18%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
-91.52%
vs the sector median at left
Pulse Biosciences, Inc.
Market Cap
$3.44B
Return on Equity (ROE)
-80.46%
TTM Avg
-85.78%
3Y Avg
-79.20%
5Y Avg
-95.27%
Market Cap
$3.47B
Return on Equity (ROE)
N/A
TTM Avg
-136.37%
3Y Avg
-87.14%
5Y Avg
-78.77%
Market Cap
$3.48B
Return on Equity (ROE)
-14.60%
TTM Avg
-18.51%
3Y Avg
-18.00%
5Y Avg
-17.65%
Market Cap
$3.38B
Return on Equity (ROE)
29.12%
TTM Avg
31.38%
3Y Avg
-1.34%
5Y Avg
-13.55%
Market Cap
$3.36B
Return on Equity (ROE)
N/A
TTM Avg
336.99%
3Y Avg
336.99%
5Y Avg
336.99%
Market Cap
$3.52B
Return on Equity (ROE)
-7.50%
TTM Avg
-76.90%
3Y Avg
-65.24%
5Y Avg
-51.68%
Market Cap
$3.54B
Return on Equity (ROE)
-32.94%
TTM Avg
-45.25%
3Y Avg
-31.88%
5Y Avg
-26.45%
Market Cap
$3.56B
Return on Equity (ROE)
8.25%
TTM Avg
3.56%
3Y Avg
-0.85%
5Y Avg
-3.10%
Market Cap
$3.57B
Return on Equity (ROE)
-12.08%
TTM Avg
-47.33%
3Y Avg
-44.55%
5Y Avg
-54.96%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | $3.44B | -80.46% | -85.78% | -79.20% | -95.27% |
| Celcuity Inc. (CELC)vs › | $3.47B | N/A | -136.37% | -87.14% | -78.77% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | -14.60% | -18.51% | -18.00% | -17.65% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 29.12% | 31.38% | -1.34% | -13.55% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | N/A | 336.99% | 336.99% | 336.99% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | -7.50% | -76.90% | -65.24% | -51.68% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | -32.94% | -45.25% | -31.88% | -26.45% |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 8.25% | 3.56% | -0.85% | -3.10% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | -12.08% | -47.33% | -44.55% | -54.96% |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | -130.98% | -34.38% | -35.20% | -30.70% |
ROE
-80.5%
ROA
-69.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -80.46% |
| 2026-03-31 | -112.47% |
| 2025-12-31 | -90.24% |
| 2025-09-30 | -80.62% |
| 2025-06-30 | -65.11% |
| 2025-03-31 | -50.86% |
| 2024-12-31 | -46.65% |
| 2024-09-30 | -58.30% |
| 2024-06-30 | -163.22% |
| 2024-03-31 | -117.25% |
| 2023-12-31 | -95.15% |
| 2023-09-30 | -75.70% |
| 2023-06-30 | -77.60% |
| 2022-06-30 | -260.38% |
| 2022-03-31 | -299.55% |
| 2021-12-31 | -178.37% |
| 2021-09-30 | -130.82% |
| 2021-06-30 | -101.44% |
| 2021-03-31 | -277.58% |
| 2020-12-31 | -217.75% |
| 2020-09-30 | -152.55% |
| 2020-06-30 | -115.15% |
| 2020-03-31 | -224.02% |
| 2019-12-31 | -152.82% |
| 2019-09-30 | -102.82% |
| 2019-06-30 | -82.53% |
| 2019-03-31 | -65.90% |
| 2018-12-31 | -56.60% |
| 2018-09-30 | -132.85% |
| 2018-06-30 | -97.07% |
| 2018-03-31 | -75.53% |
| 2017-12-31 | -55.59% |
| 2017-09-30 | -39.40% |
| 2017-06-30 | -61.90% |
| 2017-03-31 | -40.36% |
| 2016-12-31 | -37.62% |
| 2016-09-30 | -27.73% |
| 2016-06-30 | -18.74% |
| 2016-03-31 | -33.28% |
| 2015-12-31 | -20.57% |
| 2015-09-30 | -15.96% |
